No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

OpenAI nears record-breaking $40bn funding deal as valuation doubles

by
January 31, 2025
in Investing
0
OpenAI nears record-breaking $40bn funding deal as valuation doubles
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

OpenAI, the maker of ChatGPT, is in discussions to raise close to $40 billion in fresh funding—almost doubling its valuation to as high as $340 billion, according to reports.

The San Francisco-based company was last valued at $157 billion in October, when it secured $6.6 billion of investment. Microsoft led a previous round of financing totalling $10 billion, integrating OpenAI’s technology into its suite of Office products and significantly boosting the AI startup’s profile.

Under discussions first reported by The Wall Street Journal, SoftBank is poised to lead the new round with a direct investment of between $15 billion and $25 billion. A portion of the funds would fuel OpenAI’s commitment to Stargate—a joint venture between Oracle, OpenAI, and SoftBank—which has earmarked up to $500 billion to help the United States maintain a competitive edge over China in the AI space. SoftBank’s additional stake would come on top of the $15 billion it has already pledged to Stargate.

Founded in 2015 as a not-for-profit by Sam Altman, 39, Elon Musk, 53, and others, OpenAI pivoted in 2019 to a “capped-profit” model. Musk departed in 2018 due to potential conflicts with Tesla’s own AI ambitions. Under Altman, OpenAI has grown to become one of the world’s most valuable private companies and a central force in the race to commercialise AI tools powered by large language models.

However, competition is on the rise. This week, Chinese AI startup DeepSeek claimed to have developed R1, a rival chatbot to ChatGPT, at a fraction of the cost. “DeepSeek’s R1 is an impressive model, particularly around what they’re able to deliver for the price,” Altman acknowledged on X (formerly Twitter).

On Wednesday, OpenAI said it was investigating whether DeepSeek had “inappropriately distilled our models”. It added: “We take aggressive, proactive countermeasures to protect our technology and will continue working closely with the US government to protect the most capable models being built here.”

OpenAI did not respond to a request for comment on the reported new funding round.

Read more:
OpenAI nears record-breaking $40bn funding deal as valuation doubles

Previous Post

Gain Confidence on Winter Roads With DVSA’s Latest E-learning Course

Next Post

Homebase owes £650m unsecured debt as administration details emerge

Next Post
Homebase owes £650m unsecured debt as administration details emerge

Homebase owes £650m unsecured debt as administration details emerge

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023
Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

0

0

0

0
Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

May 14, 2025
Pharmaceutical Pricing Around the World

Pharmaceutical Pricing Around the World

May 14, 2025
House Republicans’ Reconciliation Bills Are Derelict on Health Reform

House Republicans’ Reconciliation Bills Are Derelict on Health Reform

May 14, 2025

How Trump Can Lower Drug Prices Without Price Controls

May 14, 2025

Recent News

Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

Republicans’ One, Big, Beautiful Tax Bill Needs a Makeover

May 14, 2025
Pharmaceutical Pricing Around the World

Pharmaceutical Pricing Around the World

May 14, 2025
House Republicans’ Reconciliation Bills Are Derelict on Health Reform

House Republicans’ Reconciliation Bills Are Derelict on Health Reform

May 14, 2025

How Trump Can Lower Drug Prices Without Price Controls

May 14, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.